ArticleMolecular & cellular proteomics : MCP2016

Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.

Valerie C Wasinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.